BusinessEarth Science Tech, Inc. Announces a Successful Two-Day SOHO ExpoBy Nasdaq OMXDec 5, 2017, 1:02 PM UTC
BusinessEarth Science Tech, Inc. Initiates Pre-Launch on its MSN-2 Human Clinical Trials with Clinique Sante AmiteBy Nasdaq OMXNov 14, 2017, 5:00 PM UTC
BusinessEarth Science Tech, Inc. Signs Agreement with TransBiotech to start in Vitro & in Vivo in Phase II for Nutraceutical PatentsBy Nasdaq OMXNov 14, 2017, 1:01 PM UTC
BusinessEarth Science Tech, Inc. Enters into a Joint Venture with Varsity Group, LLC. Under Its Wholly Owned Subsidiary KannaBidioid Inc.By Nasdaq OMXJul 6, 2017, 12:35 PM UTC
BusinessEarth Science Tech, Inc. Receives a Price Target of $4.12 from Leading Independent Equity Research & Corporate Firm, SeeThruEquityBy Nasdaq OMXJun 29, 2017, 12:45 PM UTC
BusinessEarth Science Tech, Inc. Launches Earth Science Pharmaceutical & MSN-2 Medical Device Websites, Adds Michel Gauthier M.D. to the Advisory Board, and Reports Over 80% Profit IncreaseBy Nasdaq OMXJun 19, 2017, 12:15 PM UTC
BusinessETST Launches Cannabis Therapeutics Website, Shares Updates on their CBD-Based Nutraceutical Patents, & Hints on New Products Launching May 2017By Nasdaq OMXApr 20, 2017, 11:55 AM UTC
BusinessEarth Science Tech Inc. and Cannabis Therapeutics Inc. to hold High-Level R&D Strategy Session in Laval, Qc and announces Dr. Moutih Rafei, PhD, as a new member of the Advisory BoardBy Nasdaq OMXFeb 28, 2017, 1:00 PM UTC
